PATCHVALVE: Endobronchial Valves Plus Blood Patch for Persistent Air Leaks

Recruiting N/A Interventional Study
Persistent Air Leaks
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to evaluate the real-world safety and effectiveness of combining endobronchial valve (IBV) placement with endobronchial blood patching (EBP) for the treatment of persistent air leaks (PALs) in adult patients undergoing bronchoscopy. PALs are a challenging condition often associated with prolonged hospital stays, increased morbidity, and delayed recovery. The main questio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
{Inclusion Criteria} * Adult (≥18 years) patients who have been diagnosed with persistent air leaks (PALs) due to conditions such as alveolar-pleural fistulas following pulmonary resections, traumatic injury, or underlying lung disease or other cause. * PAL patients who are deemed non-candidates fo…
Contacts

Jason Beattie, MD

3105298266

jbeattie@bidmc.harvard.edu

CONTACT

Christine Conley, MD

cconley@bidmc.harvard.edu

CONTACT